+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Japan Tissue Diagnostics Market 2019-2025

  • ID: 5013408
  • Report
  • March 2020
  • Region: Japan
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent technologies
  • Eurogentec S.A.
  • GE healthcare
  • Johnson & Johnson
  • Philips, Inc
Japan Tissue Diagnostics Market Size, Share & Trends Analysis Report by Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology And Workflow Management, Special Staining and Hematoxylin & Eosin (H&E) Stain) By Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer and Non-small Cell Lung Carcinoma) By Product (Instruments and Consumables) By End-User (Hospitals, Pharmaceuticals, Research Institute, Laboratories, and Other Research) Forecast period 2019-2025.

Japan tissue diagnostics market is anticipated to grow at a CAGR 7.0% during the forecast period. Japan is a technologically advanced nation with significant development in tissue diagnostics. A significant decline in mortality in Japan is due to the improved healthcare systems and increased awareness for cancer and other lifestyle-oriented diseases. However, stomach cancer, lung cancer, colon and rectum cancer are responsible for an average 150 fatality per 0.1 million patients. Japan’s diagnostic companies are significant providers of diagnostic solutions, instrument systems, tests, software and services that enable laboratories, hospitals, clinics that provide better and reliable results with more efficient and cost-effective methods.

The key segment of Japan tissue diagnostics market by technology includes Immunohistochemistry, In-Situ hybridization, and H&E stain business. Roche Holdings AG, Qiagen Diagnostics, Abbott Laboratories, and Agilent Technologies among others are the key companies exploring the tissue diagnostics market in Japan. Diagnostics players are effectively contributing to the market through years of R&D efforts that are coming in the near future. For instance, Roche Holdings AG has over 100 different tests for the consolidated instrument series.

Their regulatory bodies in Japan are responsible for approving healthcare devices including diagnostic devices and applications. There are two major regulatory agencies that are responsible for providing quality products without affecting patient health conditions that include the Ministry of Health Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA). Ministry of Health, Labour and Welfare (MHLW) is the key regulatory body, which creates laws and regulations for medical devices and drugs in Japan. The Pharmaceuticals and Medical Devices Agency (PMDA) also ensures product safety, efficacy and quality of pharmaceuticals and medical devices. These regulatory bodies review marketing authorization applications for pharmaceuticals and medical devices.

Research Methodology

The market study of the Japan Tissue Diagnostics market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the Healthcare industry and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Japan Tissue Diagnostics Market Research and Analysis by Technology
2. Japan Tissue Diagnostics Market Research and Analysis by Product
3. Japan Tissue Diagnostics Market Research and Analysis by Diseases
4. Japan Tissue Diagnostics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the Japan Tissue Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Japan Tissue Diagnostics market.
  • Insights about market determinants which are stimulating the Japan Tissue Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent technologies
  • Eurogentec S.A.
  • GE healthcare
  • Johnson & Johnson
  • Philips, Inc
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities

5. Market Segmentation
5.1. Japan Tissue Diagnostics Market by Technology
5.1.1. Immunohistochemistry
5.1.2. In Situ Hybridization
5.1.3. Digital Pathology And Workflow Management
5.1.4. Special Staining
5.1.5. Hematoxylin & Eosin (H&E) Stain
5.2. Japan Tissue Diagnostics Market by Diseases
5.2.1. Breast Cancer
5.2.2. Gastric Cancer
5.2.3. Lymphoma
5.2.4. Prostate Cancer
5.2.5. Non-small Cell Lung Carcinoma
5.3. Japan Tissue Diagnostics Market by Product
5.3.1. Instruments
5.3.2. Consumables
5.4. Japan Tissue Diagnostics Market by End-User
5.4.1. Hospitals
5.4.2. Pharmaceuticals
5.4.3. Research Institute
5.4.4. Laboratories
5.4.5. Other Research

6. Company Profiles
6.1. Abbott Laboratories
6.2. Agilent technologies
6.3. Becton, Dickinson and Co.,
6.4. Eurogentec S.A.
6.5. GE healthcare
6.6. Johnson & Johnson
6.7. Philips, Inc
6.8. QIAGEN AG
6.9. Roche Holdings AG
6.10. Siemens AG
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Agilent technologies
  • Becton, Dickinson and Co.,
  • Eurogentec S.A.
  • GE healthcare
  • Johnson & Johnson
  • Philips, Inc
  • QIAGEN AG
  • Roche Holdings AG
  • Siemens AG
Note: Product cover images may vary from those shown